Hyperphosphorylated cortactin in cancer cells plays an inhibitory role in cell motility

Molecular Cancer Research

Volumn 6, Issue 4, 2008, Pages 654-662

  Jia, Lin ^a   Uekita, Takamasa ^a   Sakai, Ryuichi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTACTIN; CRK ASSOCIATED SUBSTRATE PROTEIN; PROTEIN KINASE FYN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EMBRYO; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; STOMACH CANCER;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CLONE CELLS; CORTACTIN; CRK-ASSOCIATED SUBSTRATE PROTEIN; FOCAL ADHESIONS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 42049103661     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0220     Document Type: Article

References (35)

1. Schuuring E, Verhoeven E, Litvinov S, Michalides RJ. The product of the EMS1 gene, amplified and overexpressed in human carcinoma, is homologous to a v-src substrate and is located in cell-substratum contact sites. Mol Cell Biol 1993;13:2891-8.
2. Campbell DH, deFazio A, Sutherland RL, Daly RJ. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell line. Int J Cancer 1996;68:485-92.
3. Hui R, Ball JR, Macmillan RD, et al. EMS1 gene expression in primary breast cancer relationship to cyclin D1 and oestrogen receptor expression and patient survival. Oncogene 1998;17:1053-9.
4. Li Y, Tondravi M, Liu J, et al. Cortactin potentates bone metastasis of breast cancer cells. Cancer Res 2001;61:6906-11.
5. Patel AM, Incognito LS, Schechter GL, Wasilenko WJ, Somers KD. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 1996;12:31-5.
6. Freier K, Sticht C, Hofele C, et al. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 2006;45:118-25.
7. Daly RJ. Cortactin signaling and dynamic actin networks. Biochem J 2004;382:13-25.
8. Lua BL, Low BC. BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Mol Biol Cell 2004;15:2873-83.
9. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT. Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol 1998;18:5838-51.
10. Kowalski JR, Egile C, Gil S, Snapper SB, Li R, Thomas SM. Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 2005;118:79-87.
11. Wu H, Parsons JT. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993;120:1417-26.
12. Kim L, Wong TW. Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER. J Biol Chem 1998;273:23542-8.
13. Gallet C, Rosa JP, Habib A, Lebret M, Levy-Toledano S Maclouf J. Tyrosine phosphorylation of cortactin associated with Syk accompanies thromoxane analogue-induced platelet shape change. J Biol Chem 1999;274:23610-6.
14. Campbell DH, Sutherland RL, Daly RJ. Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res 1999;59:5376-85.
15. Vidal CB, Geny J, Melle M, Jandrot-Perrus M, Fontenay-Roupie. Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading implication of the cortical-actin binding protein cortactin. Blood 2002;100:4462-9.
16. Huang J, Asawa T, Takato T Sakai R. Cooperative roles of Fyn and cortactin in cell migration of metastatic murine melanoma. J Biol Chem 2003;278:48367-76.
17. Webb DJ, Parsons JT, Horwitz AF. Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol 2002;4:97-100.
18. Mitchison TJ, Cramer LP. Actin-base cell motility and cell locomotion. Cell 1996;84:371-9.
19. Honda H, Oda H, Nakamoto T, et al. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 1998;19:361-5.
20. Huang J, Hamasaki H, Nakamoto T, et al. Differential regulation of cell migration, actin stress fiber organization, and cell transformation by functional domains of Crk-associated substrate. J Biol Chem 2002;277:27265-72.
21. Sakai R, Nakamoto T, Ozawa K, Aizawa S, Hirai H. Characterization of the kinase activity essential for tyrosine phosphorylation of p130Cas in fibroblasts. Oncogene 1997;14:1419-26.
22. Yanagihara K, Tanaka H, Takigahira M, et al. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 2004;95:575-82.
23. Zhang LH, Tian B, Diao LR, et al. Dominant expression of 85-kDa form of cortactin in colorectal cancer. J Cancer Res Clin Oncol 2006;132:113-20.
24. Chuma M, Sakamoto M, Yasuda J, et al. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 2004;41:629-36.
25. Rothschild BL, Shim AH, Ammer AG, et al. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 2006;66:8017-25.
26. Barroso C, Rodenbusch SE, Welch MD, Drubin DG. A role for cortactin in Listeria monocytogenes invasion of NIH 3T3 cells, but not in its intracellular motility. Cell Motil Cytoskeleton 2006;63:231-43.
27. Nakamoto T, Sakai R, Honda H, et al. Requirements for localization of p130cas to focal adhesions. Mol Cell Biol 1997;17:3884-97.
28. Huang C, Liu J, Haudenschild CC, Zhan X. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 1998;273:25770-6.
29. Sawada Y, Tamada M, Dubin-Thaler BJ, et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 2006;127:1015-26.
30. Sakai R, Iwamatsu A, Hirano N, et al. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 1994;13:3748-56.
31. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA. CAS/Crk coupling servers as a "molecular switch" for induction of cell migration. J Cell Biol 1998;140:961-72.
32. Panetti TS. Tyrosine phosphorylation of paxillin, FAK and p130CAS: effects on cell spreading and migration. Front Biosci 2002;7:143-50.
33. Pratt SJ, Epple H, Ward M, Feng Y, Braga VM, Longmore GD. The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J Cell Biol 2005;168:813-24.
34. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 2004;24:5269-80.
35. Miyake I, Hakomori Y, Misu Y, et al. Domain-specific function of ShcC docking protein in neuroblastoma cells. Oncogene 2005;24:3206-15.